Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1982 Nov;58(685):693–696. doi: 10.1136/pgmj.58.685.693

The effects of amiodarone on thyroid function.

N S Jaggarao, J Sheldon, E N Grundy, R Vincent, D A Chamberlain
PMCID: PMC2426565  PMID: 7170269

Abstract

The effects of amiodarone on thyroid function tests in 100 patients treated for 6 weeks to 8 years are reported. One patient became thyrotoxic and 10 developed latent or overt hypothyroidism. Twenty-five patients remained clinically euthyroid throughout, but had free thyroxine indices above the normal range. In these patients with apparently anomalous results, total tri-iodothyronine was normal in 19 cases and low in 1; conversely, free thyroxine was high in all 17 cases in which it was measured. Thyrotrophin releasing hormone (TRH) tests were abnormal in 4 of the 13 patients who had the test. Reverse tri-iodothyronine was significantly raised after 2 weeks amiodarone in 5 healthy subjects, but an equivalent amount of iodine in 9 healthy individuals did not significantly affect any of these tests. We believe that these changes are due in part to inhibition of peripheral conversion of thyroxine to tri-iodothyronine with diversion to reversed tri-iodothyronine. Thyroid function tests should be checked once or twice a year in all patients on maintenance amiodarone. Tests indicating hypothyroidism are likely to be clinically relevant, whereas levels of thyroxine suggesting thyrotoxicosis may be misleading and do not usually imply the need to discontinue treatment with the drug.

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broekhuysen J., Laruel R., Sion R. Recherches dans la série des benzofurannes. XXXVII. Etude comparée du transit et du métabolisme de l'amiodarone chez diverses espèces animales et chez l'homme. Arch Int Pharmacodyn Ther. 1969 Feb;177(2):340–359. [PubMed] [Google Scholar]
  2. Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Béraud T., Vallotton M. B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest. 1976 Aug;58(2):255–259. doi: 10.1172/JCI108466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bürgi H., Wimpfheimer C., Burger A., Zaunbauer W., Rösler H., Lemarchand-Béraud T. Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab. 1976 Dec;43(6):1203–1210. doi: 10.1210/jcem-43-6-1203. [DOI] [PubMed] [Google Scholar]
  4. Chamberlain D. A., Clark A. N. Atrial fibrillation complicating Wolff-Parkinson-White syndrome treated with amiodarone. Br Med J. 1977 Dec 10;2(6101):1519–1520. doi: 10.1136/bmj.2.6101.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chopra I. J., Williams D. E., Orgiazzi J., Solomon D. H. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab. 1975 Nov;41(5):911–920. doi: 10.1210/jcem-41-5-911. [DOI] [PubMed] [Google Scholar]
  6. Felicetta J. V., Green W. L., Nelp W. B. Inhibition of hepatic binding of thyroxine by cholecystographic agents. J Clin Invest. 1980 May;65(5):1032–1040. doi: 10.1172/JCI109755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. François J. Cornea verticillata. Doc Ophthalmol. 1969;27:235–251. doi: 10.1007/BF00208693. [DOI] [PubMed] [Google Scholar]
  8. Kaplan M. M., Utiger R. D. Iodothyronine metabolism in rat liver homogenates. J Clin Invest. 1978 Feb;61(2):459–471. doi: 10.1172/JCI108957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mathur H., Ekins R. P., Brown B. L., Malan P. G., Kurtz A. B. Correction for the presence of cross-reactants in saturation assays: application to thyroxine cross-reactivity in 3,3',5'-(reverse)-triiodothyronine radioimmunoassay. Clin Chim Acta. 1979 Feb 1;91(3):317–327. doi: 10.1016/0009-8981(79)90489-3. [DOI] [PubMed] [Google Scholar]
  10. Pritchard D. A., Singh B. N., Hurley P. J. Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J. 1975 Aug;37(8):856–860. doi: 10.1136/hrt.37.8.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ratcliffe W. A., Ratcliffe J. G., McBride A. D., Harland W. A., Randall T. W. The radioimmunoassay of thyroxine in unextracted human serum. Clin Endocrinol (Oxf) 1974 Oct;3(4):481–488. [PubMed] [Google Scholar]
  12. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  13. Savoie J. C., Massin J. P., Thomopoulos P., Leger F. Iodine-induced thyrotoxicosis in apparently normal thyroid glands. J Clin Endocrinol Metab. 1975 Oct;41(4):685–691. doi: 10.1210/jcem-41-4-685. [DOI] [PubMed] [Google Scholar]
  14. Silva J. E., Larsen P. R. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J Clin Invest. 1978 May;61(5):1247–1259. doi: 10.1172/JCI109041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Verhoeven R. P., Visser T. J., Doctor R., Hennemann G., Schalekamp M. A. Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab. 1977 May;44(5):1002–1005. doi: 10.1210/jcem-44-5-1002. [DOI] [PubMed] [Google Scholar]
  16. Wolff J. Iodide goiter and the pharmacologic effects of excess iodide. Am J Med. 1969 Jul;47(1):101–124. doi: 10.1016/0002-9343(69)90245-9. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES